2016
DOI: 10.1016/j.mencom.2016.11.003
|View full text |Cite
|
Sign up to set email alerts
|

Asymmetric synthesis of 3-prenyl-substituted pyrrolidin-2-ones

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 10 publications
(5 citation statements)
references
References 32 publications
0
5
0
Order By: Relevance
“…Enantiomerically enriched Michael adduct 7 , which was obtained with catalyst ( S , S )- C5 , was also used to finish the synthesis of 4-methylpregabalin ( 1 ) in an analogy to literature procedures ( Scheme 4 ) [ 47 ]. Adduct 7 was transformed to lactone 13 via nitro group reduction with NaBH 4 /NiCl 2 followed by spontaneous lactamization.…”
Section: Resultsmentioning
confidence: 99%
“…Enantiomerically enriched Michael adduct 7 , which was obtained with catalyst ( S , S )- C5 , was also used to finish the synthesis of 4-methylpregabalin ( 1 ) in an analogy to literature procedures ( Scheme 4 ) [ 47 ]. Adduct 7 was transformed to lactone 13 via nitro group reduction with NaBH 4 /NiCl 2 followed by spontaneous lactamization.…”
Section: Resultsmentioning
confidence: 99%
“…13 C {1H} NMR (101 MHz, CDCl 3 ): δ 168.0, 167.4, 150.0, 147.7, 128.2, 120.0, 114.7, 112.0, 80.5, 77.8, 55.9, 54.9, 53.0, 52.9, 42.7, 32.8, 24.1. NMR spectra are in agreement with the literature data …”
Section: Methodsmentioning
confidence: 99%
“…mp 95−96 °C. 1 57 Dimethyl (R)-2-(4-Methyl-1-nitropentan-2-yl)malonate (1m). A 10 mL screw-cap Schlenk tube with a stirring bar was prepared according to a standard Schlenk procedure, and 15 mg (5 mol %) of the precatalyst NiBr 2 -Cat-2 was placed inside as an aliquot in chloroform followed by the addition of 9.48 mg (4 mol %) of TBAT as an aliquot in chloroform.…”
Section: Dimethyl (S)-2-(1-(3-(cyclopentyloxy)-4-methoxyphenyl)-2nitr...mentioning
confidence: 99%
“…Finally, the nitro groups can be further reduced to obtain the GABA or tryptamine scaffold, respectively. The replacement of soluble catalysts by heterogeneous counterparts simplifies the removal of the catalyst from the reaction mixture and may allow its reuse . Herein, a new family of post synthetically modified metal–organic frameworks is employed to selectively direct the different C−C bond‐forming reactions towards desired products 2 and 3 starting from benzaldehyde and nitromethane as starting materials.…”
Section: Methodsmentioning
confidence: 99%